Submitted by Anonymous (not verified) on 5 March 2026 - 13:18
Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 54, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 54, Status: Authorised